Top Story
Healthcare Marketing: Winning as the Underdog
If you are a healthcare marketer, you are also (almost certainly) an underdog marketer. So what do you do to win? Bill Drummy provides some answers that are simple to understand, but maybe difficult to implement
...Read more

Regulatory
House Overwhelmingly Approves “Cures” Legislation
Despite opposition from consumer advocates that the bill would bring unsafe and untested drugs to the market, and from conservatives about excessive costs, leaders of the House Energy & Commerce Committee last week orchestrated a 344-77 vote in favor of the long-debated “21^st Century Cures” Act. Jill Wechsler reports
...Read more

No Access, No Business: The rocky road to Market Access Excellence
Live Webinar: Tuesday, 1 September 2015 at 11 am EDT / 4 pm BST / 5 pm CEST No access = no business!
Market Access needs to be the most important function in your organization. Transforming this function to fulfill that key role is difficult, but possible. Learn in our webcast how to achieve true Excellence in Market Access and be ready for future challenges.
Register Free

Supply Chain
Re-sell vs Direct Models: US Branded Drug Distribution in the Future
The US pharmaceutical supply chain has been undergoing a drastic transition from the buy-and-hold model to the fee-for-service model in the last 10 years. Kathleen Iacocca and Yao Zhao provide insights on why direct models can be more sustainable than resell models in the long run and whether they can be implemented in the US
...Read more

On the road to integration
Moving your multichannel program into the fast lane
On Demand
Join Peter Lammers and Liz Murray from Quintiles as they present insightful research findings regarding the state of the pharmaceutical industry and the use of multi-channel marketing strategies. Learn what other industries apply successfully and get different options for you to actually “make it happen” for your product.
Learn More

Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2015
The 2015 Emerging Pharma Leaders have been selected by PharmExec's editorial staff with support from its Editorial Advisory Board. This year’s group adds to a list of more than 200 alumni dating back to June 2008. We called that first cohort of leaders “the change generation” and frankly the description remains apt today. What is different is a greater diversity in leader backgrounds and the skills required to advance to the “c-suite”
...Read more

Emerging Pharma Leaders — Slide Show
If you’re pressed for time and want just the names and faces, click here for a slide show of PharmExec's 17 Emerging Pharma Leaders 2015
...Read more

//The Board of Directors of The Female Health Company (Chicago, IL) announced that Karen King, President and CEO, has left to pursue other interests. The company's Chairman and former President and CEO, O.B. Parrish, has been reappointed to serve as CEO. //NOXXON Pharma (Boston, MA and Berlin, Germany) appointed Dr. Aram Mangasarian as CEO. //Aridis Pharmaceuticals (San Jose, CA) announced the appointment of Fred Kurland as the company's first Chief Financial Officer. //Cancer Genetics (Rutherford, NJ) appointed Rita Shaknovich, M.D., Ph.D. as Group Medical Director and Vice President of Hematopathology Services. //